✦ LIBER ✦

Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study

✍ Scribed by Deborah Watkins Bruner; Andrea Barsevick; Chunqiao Tian; Marcus Randall; Robert Mannel; David E. Cohn; Joel Sorosky; Nick M. Spirtos

Publisher: Springer Netherlands
Year: 2006
Tongue: English
Weight: 220 KB
Volume: 16
Category: Article
ISSN: 0962-9343
DOI: 10.1007/s11136-006-9003-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of cyclophosphamide a

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

✍ George Omura; John A. Blessing; Clarence E. Ehrlich; Alexander Miller; Edgardo Y 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

Randomized trial of initial therapy with

Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: Initial and long term results—Eastern Cooperative Oncology Group study E2878

✍ Scott Wadler; Beow Yeap; Steven Vogl; Paul Carbone 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## BACKGROUND. Following surgical debulking, most patients with International Federation of Gynecology and Obstetrics (FIGO) Stage 111 or IV carcinoma of the ovary receive treatment with combination chemotherapy. However, the optimal postsurgical therapy for ovarian carcinoma remains to be defined

Combined multidrug chemotherapy (vincris

Combined multidrug chemotherapy (vincristine, bleomycin, and methotrexate) and radiotherapy in advanced carcinomas of the head and neck: Results of a pilot study of the radiation therapy oncology group

✍ Victor A. Marcial; Nayda R. Figueroa; Enrique Velez-Garcia; Juan Cintron; Luis A 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 160 KB

The combination of cisplatin, doxorubici

The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for clinical research

✍ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB